This new complaint, along with a few others, centers on vision loss, alleging that Novo Nordisk failed to adequately warn users about the risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition characterized by reduced blood flow to the optic nerve
In April, Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about their versions of weight-loss drugs like Ozempic, Wegovy and Mounjaro
Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial
RYBELSUS and OZEMPIC tablets are not approved for subcutaneous use
About 1 in 8 people in the United States now take a glucagon-like peptide-1, or GLP-1, medication for weight loss, diabetes, or another condition, according to a KFF poll
5 Beyond 68 weeks Weight is largely maintained with continued medication use